The effects of soman (pinacolyl methylphosphonofluoridate) on coronary blood flow, the electrocardiogram, and cardiac function were measured in a-chloralose-anesthetized swine. Coronary blood flow (CBF), mean arterial blood pressure (MAP), peak systolic left ventricular pressure (IVP), maximum rate of left ventricular pressure development (dP/dt^), cardiac output, and the ECG were monitored continuously. A dose of 2X LD50 of soman (1 LD50 = 4.6 /xg/kg) was given at 1 LD50/min in the femoral vein, which produced an increase in coronary sinus plasma acetylcholine (ACh) from a control of 0.7 ± 0.01 nmol/ml to a maximum 314% of control at 15 min and a decrease in CBF from a control of 99 ± 13 ml/min/100 g to a minimum 55% of control at 15 min. The increase in ACh in the coronary sinus was significantly correlated with a decrease in CBF (r = -0.87, p < 0.001). The fall in CBF was accompanied by concomitant decreases in IVP, MAP, and dP/dt™,,, with S-T segment elevation and ventricular fibrillation. The increase in coronary sinus acetylcholine concentration was significantly correlated with a 10-fold fall in coronary sinus acetylcholinesterase levels from a control of 2.47 ± 0.97 mol acetylcholine hydrolyzed/ml blood/min and was consistent with the time course for the reduced hemodynamic measurements. These studies support the hypothesis that acetylcholine increases following soman toxicity may decrease coronary blood flow, thereby initiating ischemic electrocardiographs changes and reducing cardiac function. C 1996 Society of Toxi col ogy Organophosphate agents are known to cause striking cardiovascular effects in intact animals. These include bradycardia, decreased cardiac output, and hypertension followed by hypotension (Anastassiades and loannides, 1984). Electrocardiographic changes have been noted in both man and experimental animals and include prolongation of the PR interval. A-V conduction defects, and T wave and Q-T alterations (Kiss and Fazekas, 1979) . Serious ventricular arrhyth-1 Supported by USAMRDC Grants 88PP8825 and 87PP78I8. mias or S-T segment changes, indicative of myocardial infarction, have been observed in several patients with pesticide toxicity (Kiss and Fazekas, 1979; Luzhnikov et al., 1975; Sidell, 1974) . There have been no studies of the coronary circulation during organophosphate toxicity, but electrocardiogram (ECG) changes seen with pesticide toxicity are indicative of coronary vasospasm, decreased myocardial blood flow, and myocardial ischemia. Many of the deaths due to organophosphate toxicity may be due to progressive neurologic dysfunction and respiratory paralysis (Durham and Hayes, 1962 ). However, current evidence supports the hypothesis that some of the deaths from organophosphate toxicity may be due to acetylcholine-induced coronary vasospasm, followed by myocardial ischemia and cardiac dysfunction (Anastassiades and loannides, 1984).
Organophosphate agents are known to cause striking cardiovascular effects in intact animals. These include bradycardia, decreased cardiac output, and hypertension followed by hypotension (Anastassiades and loannides, 1984) . Electrocardiographic changes have been noted in both man and experimental animals and include prolongation of the PR interval. A-V conduction defects, and T wave and Q-T alterations (Kiss and Fazekas, 1979) . Serious ventricular arrhyth-1 Supported by USAMRDC Grants 88PP8825 and 87PP78I8. mias or S-T segment changes, indicative of myocardial infarction, have been observed in several patients with pesticide toxicity (Kiss and Fazekas, 1979; Luzhnikov et al., 1975; Sidell, 1974) . There have been no studies of the coronary circulation during organophosphate toxicity, but electrocardiogram (ECG) changes seen with pesticide toxicity are indicative of coronary vasospasm, decreased myocardial blood flow, and myocardial ischemia. Many of the deaths due to organophosphate toxicity may be due to progressive neurologic dysfunction and respiratory paralysis (Durham and Hayes, 1962 ). However, current evidence supports the hypothesis that some of the deaths from organophosphate toxicity may be due to acetylcholine-induced coronary vasospasm, followed by myocardial ischemia and cardiac dysfunction (Anastassiades and loannides, 1984) .
It is clear from our previous data (Cowan and McKenzie, 1990 ) that intracoronary injections of acetylcholine produce a dose-dependent vasoconstriction that is reversed with systemic atropine. Additional studies using the isolated heart have also shown acetylcholine to be a coronary vasoconstrictor in swine (Sakai, 1981) . Clinical studies in man have demonstrated either a vasodilator or a vasoconstrictor effect (Horio et ai, 1986; Ludmer et al., 1986) . Studies utilizing the canine model have shown systemic vasodilatation and some compensatory splanchnic vasoconstriction with the organophosphate sarin, implicating the release of systemic acetylcholine (Daly and Wright, 1956) . Work by Feigl (1969) has shown that the coronary vascular bed of the dog vasodilates with acetylcholine. Dog, rabbit, and rat coronary arteries vasodilate to acetylcholine (Kalsner, 1985) , while human (Ginsburg, 1984) , monkey (Taira et ai, 1983) , and swine (Ito et ai, 1979) coronary arteries demonstrate vasoconstriction with the application of acetylcholine in vitro. Taira et al. (1983) demonstrated coronary vasoconstriction in the anesthetized baboon with both bolus injections and infusions of acetylcholine. Endo et al. (1976) have shown coronary arteriograms associated with Prinzmetal's variant angina in humans induced by the parasympathomimetic agents methacholine and pilocarpine. Recent studies in humans by Ludmer et al. (1986) demonstrated acetylcholine dose-dependent coronary vasoconstriction in large conductance ar-teries with advanced stenosis, while normal vessels demonstrated slight dose-dependent vasodilation with acetylcholine injection. However, further studies from Horio et al. (1986) demonstrated acetylcholine-mediated vasoconstriction in both healthy vessels and stenotic vessels in a larger population group. Our studies using the swine model were designed to specifically measure the effects of increased plasma acetylcholine as mediated by the organophosphate soman (pinacolyl methylphosphonofluoridate) on coronary blood flow, cardiac function, myocardial metabolism, and electrocardiographic changes.
METHODS
Nine male, Yorkshire swine weighing 23.8 ± 0.9 kg were sedated with ketamine (12 mg/kg, im) and anesthetized with a-chloralose (70-80 mg/ kg, iv). The trachea was intubated with an 8-mm endotracheal tube, and the animal was ventilated with a Harvard respirator. Atelectasis was prevented with 3-5 cm H 2 O positive-end expiratory pressure. An 8F Millar Mikro-tip dual-pressure transducer catheter was advanced from the right femoral artery to the left ventricle. The catheter was positioned so that one of the pressure transducers was in the ventricular cavity to record intraventricular pressure and the other transducer was in the root of the aorta to record arterial blood pressure. The left femoral artery and vein were catheterized for arterial blood sample withdrawal and to establish an iv route for administration of agents. The femoral vein was cathetenzed with a cardiac output thermodilution catheter which was advanced to the pulmonary artery for determination of cardiac output. The chest was opened with a left lateral thoracotomy at the fourth intercostal space. The pericardium was incised longitudinally and sewn to the chest wall to form a pericardial cradle. The hemizygous vein was ligated, and a catheter was advanced through the left jugular vein into the coronary sinus for collection of pure coronary sinus blood. The proximal one-fourth of the left anterior descending coronary artery (LAD) was circumferentially isolated, 5 to 10 mm from the root of the aorta. Great care was taken not to damage the vessel or the surrounding nerves. An electromagnetic flow probe was placed around the LAD. The ECG was monitored continuously from the V 4 position in the pig, which is 3 cm below the point of maximum impact of the left ventricle on the left lateral chest wall. The animals were allowed to stabilize for 30 min, during which time the animals' blood gases and pH were corrected to normal physiological limits (PO 2 80-90 mmHg, PCO 2 30-40 mmHg, and pH 7.4-7.5) by adjusting the tidal volume and rate of the respirator. The plane of anesthesia was evaluated frequently and supplemental anesthesia was administered as necessary. Hemodynamic parameters including heart rate, arterial blood pressure, peak systolic left intraventricular pressure, maximum rate of left ventricular pressure development (dP/dt), and left anterior descending coronary blood flow (CBF) were continuously measured. Arterial and coronary sinus blood samples were collected for baseline oxygen content, PO 2 , PCO 2 , pH, acetylcholine, acetylcholinesterase, lactate, and pyruvate.
A dose of 2x LD50 of soman (1 LD50 = 4.6 jig/kg) was given at 1 LD5Q/min in the femoral vein following the 30-min stabilization period to produce a rapid effect with clinically relevant dose exposure. Arterial and coronary sinus blood samples were collected at 2, 5, 10, 15, and 30 min.
Two of the nine pigs were instrumented as outlined above with the addition of a small indwelling catheter in the LAD coronary artery that was inserted for intracoronary injections. Fifteen minutes following soman injection, 40 fig of atropine was injected into the coronary catheter while hemodynamic parameters were monitored.
Chemical Analysis
A blood gas analyzer (ABL-3 blood gas analyzer, Radiometer Instruments Inc., Copenhagen, Denmark) was used to assess PO 2 , PCO 2 , and pH. Total oxygen content was measured with an oxygen analyzer (OSM3 Hemoximeter, Radiometer Instruments, Inc.). Blood lactate was determined with a YSI lactate analyzer and pyruvate concentrations were analyzed by the spectrophotometric method of Hohorst (1955) .
Plasma acetylcholine. Two milliters of blood was collected into chilled glass tubes containing sodium heparin (143 USP units) as an anticoagulant and the cholinesterase inhibitor neostigmine bromide (100 ^1 of 6.06 mg/ 100 ml saline in 2 ml of blood) to assure no further breakdown of plasma acetylcholine (Scudamore et al., 1951) . Blood samples were centrifuged immediately at 10,000 rpm for 10 min at 4°C to prevent acetylcholine uptake by the red blood cells. Plasma was then decanted into ice-cold 0.5 N perchloric acid (1 ml plasma, 2 ml PCA) for deproteinization. Samples were mixed thoroughly and centrifuged for 10 min at 4°C and 10,000 rpm. The supernatants were transferred to polyethylene centrifuge tubes and neutralized to pH 4.2-4.4 with potassium hydroxide. The samples were mixed and centrifuged for 20 min at 4°C and 16,000 rpm. Supernatant was then transferred into 2 ml chloroform, vortexed, and centrifuged for 10 min at 10,000 rpm. The top aqueous layer was then flushed through a previously washed Sep-Pak (Waters) and eluted with 1 ml distilled water. Dowex (25 mg) was then added to each sample; samples were allowed to shake for 10 min. The samples were recentrifuged for 10 min at 10,000 rpm and the supernatant was decanted and dried by evaporation. Residue was reconstituted in mobile phase consisting of 50 HIM Na 2 HPO 4 , pH 8.5, to a total of 900 fi\. Concentrations of acetylcholine were measured by high-pressure liquid chromatography using an immobilized enzyme postcolumn reactor (IEPCR) (Potter et al., 1984; Damsma et al, 1985) . The assay involves the chromatographic separation of the analytes followed by passage of the eluent through an IEPCR. In the reactor, two enzymes (acetylcholinesterase and choline oxidase) are coimmobilized. When acetylcholine is present in the effluent, dissolved oxygen is converted to H 2 O 2 via successive reactions. The resultant time-resolved H 2 O 2 peaks are detected amperometrically at a platinum electrode. Acetylcholine standards were prepared in 0.03% glacial acetic acid solution and refrigerated. Hydrogen peroxide standards were prepared in deionized water daily. The flow rate of the mobile phase was 1.0 ml/min. Quantitation of the acetylcholine was based on comparison of peak height and peak area with known standards. The limit of sensitivity of this method is 5 pmol/20 fA.
Blood acetylcholinesterase.
The blood acetylcholinesterase (AChE) was measured by the method of Ellman et al. (1961) . A spectrophotometer set at 412 nm was used to observe changes in absorbance over time. AChE standards were prepared in 50 mM, pH 7.2, phosphate buffer. Ten microliters of whole blood was added to 6 ml of 0.1 M, pH 8, phosphate buffer. Samples were gently inverted to suspend cells. One milliliter of this suspension was added to each of two cuvettes containing 10 /il of 0.01 M dithiobisnitrobenzoic acid (DTNB). Ten microliters of 0.075 M acetylthiocholine iodide was then added to one of the cuvettes. The other cuvette was used as a blank. The enzyme assay involved rapid colorimetric determination of AChE activity. Samples containing AChE were added to a reagent (DTNB). The substrate acetylthiocholine was added producing a yellow color detected spectrophotometrically.
Data Analysis
Myocardial oxygen consumption (MVO 2 ) for all experiments was calculated as arterial oxygen content minus coronary sinus oxygen content times mean coronary blood flow (ml/min/100 g tissue). Coronary vascular resistance was expressed as mean coronary vascular resistance (mean arterial blood pressure/mean coronary blood flow). Total peripheral resistance was calculated as mean arterial blood pressure/cardiac output Statistical analysis of the data was done by multifactorial analysis of variance for repeated measures. Differences between groups were evaluated by the Duncan multiple-range test. Student's group t test was used for appropriate comparison of means. The 0.05 level of significance was used to evaluate the statistical differences (Snedecor, 1956 
RESULTS
Tables 1-4 illustrate hemodynamic data, blood values, metabolic parameters, and neurochemistries as measured through the experiment. These data demonstrate that all animals start from similar basal states and that control values are similar to values reported in the literature (Hannon et al., 1990) . The hemodynamic, metabolic, and neural response to soman for the first 15 min was similar in all pigs tested; however, the time course for cardiac death was not similar in all animals. The pigs died between 10 and 60 min following soman injection. Of the seven animals not treated with atropine, only two animals survived past 30 min; therefore, the 30-min period represents n = 2 in all cases. Sixty-minute data are not presented, since only one pig remained at that time point. Figure 1 is a representative trace of the first 5 min following soman injection. All of the animals tested demonstrated a fall in heart rate, with values at 5, 10, and 15 min being statistically different from control (Table 1) . Mean arterial blood pressure was significantly reduced at 2 min and time points following. Left ventricular peak systolic pressure demonstrates a fall at the 5-, 10-, and 15-min time points. The product of peak systolic left ventricular pressure and heart rate was reduced at 5, 10, and 15 min. The reduction in intraventricular pressure was associated with a reduction in the first derivative of the ventricular systolic pressure wave, dP/dtmu. Cardiac output fell precipitously over the first 5 min and then remained at the nadir for the next 5 min. As reported in the literature (Anastassiades and Ioannides, 1984) , there was a tendency for total peripheral resistance to rise over the first 2 min and then fall to the nadir at the 15-min point. Coronary blood flow fell continuously throughout the experiment from a control of 99 ± 13 to 55 ± 31 ml/min/100 g at the 15-min time point. Coronary vascular resistance was stable during the first 2 min, and then decreased with the fall in coronary blood flow and mean arterial blood pressure. All of the pigs demonstrated changes in electrical conduction and rhythm (Fig. 2) . Five of the seven pigs displayed some type of ischemic changes on the ECG, and the remaining two pigs had lethal bradyarrhythmias.
Cardiac Performance
In the two pigs that were given intracoronary atropine coronary blood flow increased immediately to above control values and ventricular function increased, but did not reach control levels. The right coronary and the circumflex branch of the left coronary were not perfused with atropine; therefore, there was a significant portion of the myocardium that was not effected by the muscarinic blocker. The change in coronary blood flow to this point seems to be related to the fall in ventricular function, both in pressure production and in volume output. Table 2 shows that MV0 2 fell from 11.3 ± 1.6 to 8.0 ± 4.0 mlO 2 /min/100 g over the first 15 min, with the nadir occurring at 10 min with a MV0 2 of 6.2 ± 2.2 mlO 2 /min/ 100 g. The percentage of myocardial oxygen extraction in the control period was 77.7 ± 2.6% and by the 15 min sample it was significantly increased to 86.7 ± 3.8%. This increase in percentage of extraction indicates a supply limited MVO 2 . The rise in coronary sinus hydrogen ion concentration, which is shown as a fall in pH, is further indication that CBF was not matched with oxygen supply during the 15-min period.
Myocardial Oxygen Consumption and Metabolism
Coronary sinus lactate increased 233% over 15 min (Table  3 ). The rapid rise in coronary sinus lactate occurred between the 5-and 10-min samples. Although the rise in coronary sinus lactate was related to increases in the arterial lactate levels, the A-V lactate difference was decreased during the 10-min sample. Lactate consumption fell from control, reaching the lowest point at the 10-min sample. These changes in metabolism are emphasized by the increase in 11.1 + 0.7 11.3 ± 0.6 10.6 ± 1.4 11.6 ± 1.2 12.4 ± 1.3 10.2 ± 1 3 MVO 2 , ml (Vmin/100 g 11.3 + 1.6 9.6 ± 1.9 7.3 + 1.7* 6.2 + 2.2* 8.0 ±4 0* 8.2 ± 2.9
Note. Art (arterial), Cor sin (coronary sinus) Values are means ± SEM 'Significantly different from control (p < 0.05).
the lactate/pyruvate ratio, indicating a switch from aerobic to anaerobic metabolism.
Myocardial Acetylcholinesterase and Acetylcholine
Arterial and coronary sinus acetylcholinesterase levels fell dramatically over the first 2 min as shown in table 4. Plasma levels of acetylcholine in arterial and coronary sinus blood following soman injection are inversely correlated (r = -0.77, p < 0.05) with the acetylcholinesterase levels. During the first 10 min there was a 243% increase in coronary sinus acetylcholine levels from a control value of 0.7 ± 0.1 to 1.7 ± 0.4 nmol. The increased coronary sinus ACh concentrations were significantly correlated (r = -0.87, p < 0.001) with reductions in CBF.
DISCUSSION
These findings indicate a role for acetylcholine as a mediator of reduced coronary blood flow, increased arrhythmias, and decreased cardiac function during soman toxicity in the anesthetized swine model. They do not elucidate the mechanism for reduced coronary blood flow, nor do they specifically clarify the sequence of events leading to ventricular fibrillation and cardiac arrest. These findings are consistent with the hypothesis that reductions in coronary blood flow are related to increased concentrations of acetylcholine, and that ventricular arrhythmias and hemodynamic disfunction are correlated to the reduced coronary blood flow.
Current clinical hemodynamic and electrocardiographic evidence supports the hypothesis that some of the deaths from organophosphate toxicity may be due to acetylcholineinduced coronary vasospasm, followed by myocardial ischemia and cardiac disfunction (Kiss and Fazekas, 1979; Luzhnikov etal., 1975; Sidell, 1974) . Serious ventricular arrhythmias and electrocardiographic signs of myocardial infarction have been observed in patients with pesticide toxicity (Kiss and Fazekas, 1979; Luzhnikov et al., 1975) . Although there are no quantitative studies evaluating the effects of soman toxicity on coronary vasospasm, Ludmer et al. (1986) , have demonstrated that acetylcholine is a coronary vasospastic agent in patients with vascular lumenal irregularities.
Previous data from our laboratory demonstrated a dosedependent, acetylcholine-mediated reduction in coronary blood flow in the swine (Cowan and McKenzie, 1990 ). This present study supports the hypothesis that a correlation exists between the reduction in coronary blood flow and increases in plasma acetylcholine following soman injection. However, there may be two pathophysiological mechanisms leading to cardiac death. In addition to the hypothesis that there is coronary vasospasm leading to decreased oxygen delivery, decreased cardiac function, cellular death, and arrhythmias, there may also be an acetylcholine-mediated decrease in total peripheral resistance, a fall in mean arterial blood pressure, and the appearance of cardiogenic shock leading to decreased coronary blood flow and arrhythmias. In all animals, total peripheral resistance and mean arterial blood pressure were significantly reduced, with mean arterial blood pressure falling below the autoregulatory range for the coronary circulation by the 5-min period. However, it does appear from rapid tracings that the coronary blood flow reductions precede hemodynamic disfunction and electrocardiographic changes. The initial fall in intraventricular pressure, dP/dt, mean arterial blood pressure, cardiac output, and pressure rate product appear to be related to the fall in coronary blood flow and the subsequent reduction in oxygen delivery. In addition, the two pigs that were given intracoronary injections of atropine following soman infusion demonstrated an immediate increase in coronary blood flow and ventricular function. Since these injections were made directly into the LAD, these data support the hypothesis that the soman insult was an acetylcholine-mediated vasoconstriction.
Electrophysiological data would suggest that the reductions in heart rate may be related to the increased levels of acetylcholine at the sinoatrial node. The hypothesis that the decreased function was at least in part related to ischemia is supported by ECG changes. The classic S-T segment elevation was seen 5 min after soman infusion, and continued S-T elevation with inverted T wave was seen 7 min after the administration of the agent. Ventricular fibrillation resulted in cardiac death between 13 and 35 min following soman in six of the seven pigs. These ECG changes are classic signs of the reduced coronary blood flow and diminished oxygen supply which defines coronary ischemia. Only one pig was able to function with S-T elevation and ventricular arrhythmias through 60 min.
The metabolic data add support for soman related myocardial ischemic changes. Myocardial oxygen consumption decreased over the first 10 min even though oxygen extraction was increasing. Lactate consumption also decreased over the first 10 min, with a significant increase in the coronary sinus lactate/pyruvate ratio, indicating a switch from aerobic to anaerobic myocardial metabolism. Arterial blood gasses remained within the physiological range over the entire experiment. These metabolic data would imply that the reduction of coronary blood flow is not the result of reduced myocardial oxygen demand as a consequence of the decreased pressure development and cardiac output. These data support the hypothesis that the oxygen supply via coronary blood flow is reduced and that flow reductions may be related to decreased cardiac function.
Coronary sinus acetylcholinesterase values demonstrate a rapid reduction over the first 2-min concomitant and then a slight rebound which never returns to control values, but is greater than the 2-min value. With the reduction in cholinesterase activity we measured an increase in coronary sinus acetylcholine levels. Coronary sinus acetylcholine levels appeared to increase much more rapidly than arterial levels. The rapid increase in coronary sinus acetylcholine could be related to enhanced acetylcholine production, diminished acetylcholine breakdown, or the difference in the size of the coronary sinus versus the arterial pool. The changes in acetylcholine concentrations are consistent with the time course for the hemodynamic measurements. The rise in plasma acetylcholine was always accompanied by a concomitant fall in coronary blood flow, which is demonstrated by a significant curvilinear relationship (r = -0.87, p < 0.001).
In conclusion, these data demonstrate a correlation between the fall in plasma acetylcholinesterase and the rise in acetylcholine, with a specific increase in coronary sinus acetylcholine. Furthermore, the threefold increase in acetyl-choline also correlated with a significant twofold decrease in coronary blood flow. All animals in this study demonstrated a similar temporal pattern which included a fall in coronary blood flow, cardiac function, and an increase in ventricular arrhythmias. However, variation existed between individual animals, which implies animal-to-animal variability to the effect of soman. There are not enough data to evaluate the mechanisms leading to the animal-to-animal variabilities, but there could be differences in the rate of ACh or acetylcholinesterase production or the muscarinic receptor populations. It is clear that the pathophysiological response of the swine to soman injection is similar to clinical responses observed in man exposed to organophosphate poisoning. We believe that research leading to a better understanding of the mechanisms of acetylcholine mediated vasoconstriction may facilitate better overall management of the chemical casualty. Therefore, it appears that the swine is a good model to study the effects of organophosphate toxicity and additional research may help to determine whether a significant potential exists for myocardial ischemia and adverse hemodynamic effects resulting from the use of nerve agent.
